Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) Gross Profit: 2011-2024

Historic Gross Profit for Niagen Bioscience (NAGE) over the last 12 years, with Dec 2024 value amounting to $61.6 million.

  • Niagen Bioscience's Gross Profit rose 35.02% to $21.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $79.7 million, marking a year-over-year increase of 41.47%. This contributed to the annual value of $61.6 million for FY2024, which is 21.28% up from last year.
  • According to the latest figures from FY2024, Niagen Bioscience's Gross Profit is $61.6 million, which was up 21.28% from $50.8 million recorded in FY2023.
  • In the past 5 years, Niagen Bioscience's Gross Profit ranged from a high of $61.6 million in FY2024 and a low of $35.3 million during FY2020.
  • For the 3-year period, Niagen Bioscience's Gross Profit averaged around $51.7 million, with its median value being $50.8 million (2023).
  • Data for Niagen Bioscience's Gross Profit shows a peak YoY spiked of 36.89% (in 2020) over the last 5 years.
  • Over the past 5 years, Niagen Bioscience's Gross Profit (Yearly) stood at $35.3 million in 2020, then grew by 17.62% to $41.5 million in 2021, then increased by 3.15% to $42.8 million in 2022, then grew by 18.65% to $50.8 million in 2023, then increased by 21.28% to $61.6 million in 2024.